ORAGENICS, INC. Increase Decrease In Operating Lease Liability
ORAGENICS, INC. (OGEN) reported Increase Decrease In Operating Lease Liability of -$9.81 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-03-16
- ORAGENICS, INC. increase decrease in operating lease liability for the quarter ending 2024-12-31 was $0.00.
- ORAGENICS, INC. increase decrease in operating lease liability for the quarter ending 2024-09-30 was $0.00.
- ORAGENICS, INC. increase decrease in operating lease liability for the quarter ending 2024-06-30 was $0.00.
- ORAGENICS, INC. increase decrease in operating lease liability for the quarter ending 2024-03-31 was -$9.81K.
- ORAGENICS, INC. increase decrease in operating lease liability for fiscal 2024 was -$9.81K.
- ORAGENICS, INC. increase decrease in operating lease liability for fiscal 2023 was -$347.07K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $0.00 derived: sum of 2 quarters · filed 2026-03-16 | $0.00 derived: sum of 3 quarters · filed 2026-03-16 | -$9.81K 10-K · filed 2026-03-16 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | -$9.81K 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$9.81K 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | -$9.81K 10-Q · filed 2025-05-09 | |||
| 2023-12-31 | -$347.07K 10-K · filed 2025-03-14 | |||
| 2023-03-31 | -$50.24K 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | $47.33K 10-Q · filed 2023-05-12 | |||
| 2022-03-31 | -$47.33K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |